Osteopontin is induced by TGF-β2 and regulates metabolic cell activity in cultured human optic nerve head astrocytes

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Neumann, Carolin ^a   Garreis, Fabian ^a   Paulsen, Friedrich ^a   Hammer, Christian M ^a   Birke, Marco T ^b   Scholz, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; ALPHA9 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA5 INTEGRIN; CD51 ANTIGEN; HERMES ANTIGEN; INTEGRIN RECEPTOR; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL ACTIVITY; CELL METABOLISM; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLAUCOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; NERVE CELL CULTURE; OPN GENE; OPTIC NERVE HEAD ASTROCYTE; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADOLESCENT; ADULT; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; MIDDLE AGED; OPTIC DISK; PATHOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; ASTROCYTES; CELLS, CULTURED; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLAUCOMA; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPTIC DISK; OSTEOPONTIN; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA2; YOUNG ADULT;

EID: 84899554183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092762     Document Type: Article

References (63)

1. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90: 262-267.
2. Diekmann H, Fischer D (2013) Glaucoma and optic nerve repair. Cell Tissue Res. 353(2): 327-37.
3. Nickells RW, Howell GR, Soto I, John SW (2012) Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci 35: 153-179.
4. Tektas OY, Lutjen-Drecoll E, Scholz M (2010) Qualitative and quantitative morphologic changes in the vasculature and extracellular matrix of the prelaminar optic nerve head in eyes with POAG. Invest Ophthalmol Vis Sci 51: 5083-5091.
5. Lutjen-Drecoll E (2005) Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp Eye Res 81: 1-4.
6. Gottanka J, Kuhlmann A, Scholz M, Johnson DH, Lutjen-Drecoll E (2005) Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 46: 4170-4181. (Pubitemid 44264620)
7. Fuchshofer R, Birke M, Welge-Lussen U, Kook D, Lutjen-Drecoll E (2005) Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 46: 568-578. (Pubitemid 40270337)
8. Neumann C, Yu A, Welge-Lussen U, Lutjen-Drecoll E, Birke M (2008) The effect of TGF-beta2 on elastin, type VI collagen, and components of the proteolytic degradation system in human optic nerve astrocytes. Invest Ophthalmol Vis Sci 49: 1464-1472.
9. Wordinger RJ, Fleenor DL, Hellberg PE, Pang IH, Tovar TO, et al. (2007) Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci 48: 1191-1200. (Pubitemid 351261414)
10. Fuchshofer R, Tamm ER (2012) The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res 347: 279-290.
11. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E (2003) The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res 77: 757-765. (Pubitemid 37373590)
12. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E (2001) Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 239: 199-207. (Pubitemid 32422026)
13. Tripathi RC, Li J, Chan WF, Tripathi BJ (1994) Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 59: 723-727.
14. Anderson MG, Libby RT, Mao M, Cosma IM, Wilson LA, et al. (2006) Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol 4: 20.
15. Heiduschka P, Julien S, Schuettauf F, Schnichels S (2010) Loss of retinal function in aged DBA/2J mice - New insights into retinal neurodegeneration. Exp Eye Res 91: 779-783.
16. Howell GR, Libby RT, John SW (2008) Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection. Prog Brain Res 173: 303-321.
17. Inman DM, Sappington RM, Horner PJ, Calkins DJ (2006) Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci 47: 986-996. (Pubitemid 46768331)
18. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH (2005) Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171: 313-325. (Pubitemid 41540023)
19. Scholz M, Buder T, Seeber S, Adamek E, Becker CM, et al. (2008) Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest Ophthalmol Vis Sci 49: 613-621.
20. Birke MT, Neumann C, Birke K, Kremers J, Scholz M (2010) Changes of osteopontin in the aqueous humor of the DBA2/J glaucoma model correlated with optic nerve and RGC degenerations. Investigative ophthalmology & visual science 51: 5759-5767.
21. Wang KX, Denhardt DT (2008) Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev.
22. Hashimoto M, Sun D, Rittling SR, Denhardt DT, Young W (2007) Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J Neurosci 27: 3603-3611. (Pubitemid 46515142)
23. Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arteriosclerosis, thrombosis, and vascular biology 27: 2302-2309. (Pubitemid 350203943)
24. Comi C, Carecchio M, Chiocchetti A, Nicola S, Galimberti D, et al. (2009) Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline. J Alzheimers Dis.
25. Iczkiewicz J, Jackson MJ, Smith LA, Rose S, Jenner P (2006) Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease. Brain Res 1118: 239-250. (Pubitemid 44740248)
26. Jin JK, Na YJ, Moon C, Kim H, Ahn M, et al. (2006) Increased expression of osteopontin in the brain with scrapie infection. Brain Res 1072: 227-233. (Pubitemid 43255469)
27. Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, et al. (2007) Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol Dis 25: 473-482.
28. Meller R, Stevens SL, Minami M, Cameron JA, King S, et al. (2005) Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab 25: 217-225. (Pubitemid 40171203)
29. Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S (2006) Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain : a journal of neurology 129: 1426-1437.
30. McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. 8: 913-919.
31. Yu AL, Fuchshofer R, Birke M, Priglinger SG, Eibl KH, et al. (2007) Hypoxia/reoxygenation and TGF-beta increase alphaB-crystallin expression in human optic nerve head astrocytes. Experimental eye research 84: 694-706. (Pubitemid 46400636)
32. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
33. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512. (Pubitemid 26044470)
34. Yu AL, Birke K, Moriniere J, Welge-Lussen U (2010) TGF-{beta}2 induces senescence-associated changes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 51: 5718-5723.
35. Gottanka J, Chan D, Eichhorn M, Lutjen-Drecoll E, Ethier CR (2004) Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci 45: 153-158. (Pubitemid 38055681)
36. Padanilam BJ, Martin DR, Hammerman MR (1996) Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 137: 2133-2140. (Pubitemid 26133986)
37. Zhang GX, Zhao ZQ, Wang HD, Hao B (2004) Enhancement of osteopontin expression in HepG2 cells by epidermal growth factor via phosphatidylinositol 3-kinase signaling pathway. World J Gastroenterol 10: 205-208.
38. Noda M, Yoon K, Prince CW, Butler WT, Rodan GA (1988) Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor. J Biol Chem 263: 13916-13921.
39. Gross TS, King KA, Rabaia NA, Pathare P, Srinivasan S (2005) Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen. J Bone Miner Res 20: 250-256.
40. Okamoto H (2007) Osteopontin and cardiovascular system. Mol Cell Biochem 300: 1-7.
41. Heguy A, O'Connor TP, Luettich K, Worgall S, Cieciuch A, et al. (2006) Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med (Berl) 84: 318-328.
42. Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30-31: 92-102. (Pubitemid 29028730)
43. Lee MY, Shin SL, Choi YS, Kim EJ, Cha JH, et al. (1999) Transient upregulation of osteopontin mRNA in hippocampus and striatum following global forebrain ischemia in rats. Neurosci Lett 271: 81-84.
44. Chidlow G, Wood JP, Manavis J, Osborne NN, Casson RJ (2008) Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest Ophthalmol Vis Sci 49: 762-771.
45. Del Rio P, Irmler M, Arango-Gonzalez B, Favor J, Bobe C, et al. (2011) GDNF-induced osteopontin from Muller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 59: 821-832.
46. Wahl V, Vogler S, Grosche A, Pannicke T, Ueffing M, et al. (2013) Osteopontin inhibits osmotic swelling of retinal glial (Muller) cells by inducing release of VEGF. Neuroscience.
47. Kazanecki CC, Uzwiak DJ, Denhardt DT (2007) Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 102: 912-924. (Pubitemid 350036931)
48. Hernandez MR (2000) The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 19: 297-321.
49. Hernandez MR, Miao H, Lukas T (2008) Astrocytes in glaucomatous optic neuropathy. Prog Brain Res 173: 353-373.
50. Pena JD, Agapova O, Gabelt BT, Levin LA, Lucarelli MJ, et al. (2001) Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci 42: 2303-2314. (Pubitemid 32848860)
51. Iyer P, Maddala R, Pattabiraman PP, Rao PV (2012) Connective tissue growth factor-mediated upregulation of neuromedin U expression in trabecular meshwork cells and its role in homeostasis of aqueous humor outflow. Invest Ophthalmol Vis Sci 53: 4952-4962.
52. Junglas B, Yu AH, Welge-Lussen U, Tamm ER, Fuchshofer R (2009) Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp Eye Res 88: 1065-1075.
53. Eitzman DT, Ginsburg D (1997) Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo. Adv Exp Med Biol 425: 131-141. (Pubitemid 28035778)
54. Yu AL, Moriniere J, Birke M, Neumann C, Fuchshofer R, et al. (2009) Reactivation of optic nerve head astrocytes by TGF-beta2 and H2O2 is accompanied by increased Hsp32 and Hsp47 expression. Invest Ophthalmol Vis Sci 50: 1707-1717.
55. Kohan M, Breuer R, Berkman N (2009) Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 41: 290-296.
56. Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, et al. (2005) Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2: e251.
57. Sabo-Attwood T, Ramos-Nino ME, Eugenia-Ariza M, Macpherson MB, Butnor KJ, et al. (2011) Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis. Am J Pathol 178: 1975-1985.
58. Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, et al. (2009) Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 119: 1583-1594.
59. Abu El-Asrar AM, Imtiaz Nawaz M, Kangave D, Siddiquei MM, Geboes K (2012) Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders. Mediators of inflammation 2012: 493043.
60. Saika S, Miyamoto T, Ishida I, Ohnishi Y, Ooshima A (2003) Osteopontin: a component of matrix in capsular opacification and subcapsular cataract. Invest Ophthalmol Vis Sci 44: 1622-1628. (Pubitemid 36378590)
61. Hernandez MR, Andrzejewska WM, Neufeld AH (1990) Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma. Am J Ophthalmol 109: 180-188. (Pubitemid 20048416)
62. Tambuyzer BR, Casteleyn C, Vergauwen H, Van Cruchten S, Van Ginneken C (2012) Osteopontin alters the functional profile of porcine microglia in vitro. Cell Biol Int 36: 1233-1238.
63. Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, et al. (2000) Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol 20: 2734-2742.